Risk factors of gastrointestinal bleeding with dabigatran etexilate for stroke prevention in atrial fibrillation patients and its preventive strategies

新型口服直接凝血酶抑制剂达比加群酯预防卒中疗效确切,但消化道出血风险不容小视。本文结合近5年达比加群酯用于预防心房颤动患者脑卒中时致消化道出血的临床随机试验和详细个案报道,对达比加群酯致消化道出血的可能危险因素、预防达比加群酯致消化道出血的措施等作一综述。临床医师应权衡应用达比加群酯的利弊,保证治疗的安全、有效。Dabigatran etexilate, a new direct thrombin inhibitor, has precise clinical curative effect on reducing the risk of stroke in patients with atrial fibrillation, but the risk for major gastrointestinal bleeding is significant. This paper reviewed risk factors and preventive strategies of gastrointestinal bleeding with dabigatran etexilate for stroke in atrial fibrillation patients according to randomized trials and case reports in recent five years. Clinician should balance the risk of bleeding with treatment outcome of dabigatran etexilate to ensure the effectiveness and safety of treatment

某院胃食管反流病诊疗现状分析

背景:胃食管反流病(GERD)的发生率逐年上升且复发率高,但部分患者对质子泵抑制剂(PPI)的疗效欠佳。规范临床诊疗行为、提高患者用药依从性对提高GERD疗效非常重要。目的:了解某院GERD的诊疗现..

中国式学科评估:问题与出路

今年四月份,教育部学位与研究生教育发展中心(以下简称"教育部学位中心")邀请全国学位授予单位参加全国第四轮一级学科整体水平评估。随之,各个高校展开了一场大规模、高级别的学科评估申报及材料提交总动员。第四轮学科评估自发布起也引发了学界的广泛关注和热烈讨论。高等教育是中国崛起的思想发动机,关涉民族复兴的未来,而学科评估是近年来中国高等教育学科建设成就的集中展示,其意义和影响可谓深远。为了更好推进学科评估科学进行,特别是促进高等教育健康发展,《探索与争鸣》编辑部邀请全国